| Anaemia | Blood and lymphatic system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG00023 affected2,914 at risk
- EG00136 affected2,937 at risk
|
| Coagulopathy | Blood and lymphatic system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Disseminated intravascular coagulation | Blood and lymphatic system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Haemolytic anaemia | Blood and lymphatic system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Haemorrhagic anaemia | Blood and lymphatic system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0014 affected2,937 at risk
|
| Heparin-induced thrombocytopenia | Blood and lymphatic system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Iron deficiency anaemia | Blood and lymphatic system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0004 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Leukopenia | Blood and lymphatic system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Lymphadenopathy | Blood and lymphatic system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Microcytic anaemia | Blood and lymphatic system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Neutropenia | Blood and lymphatic system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Polycythaemia | Blood and lymphatic system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Thrombocytopenia | Blood and lymphatic system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0005 affected2,914 at risk
- EG0015 affected2,937 at risk
|
| Acute coronary syndrome | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0016 affected2,937 at risk
|
| Acute left ventricular failure | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Acute myocardial infarction | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Angina pectoris | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG00034 affected2,914 at risk
- EG00136 affected2,937 at risk
|
| Angina unstable | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG00113 affected2,937 at risk
|
| Aortic valve stenosis | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Arrhythmia | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0005 affected2,914 at risk
- EG0014 affected2,937 at risk
|
| Arteriosclerosis coronary artery | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Atrial fibrillation | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG00084 affected2,914 at risk
- EG00195 affected2,937 at risk
|
| Atrial flutter | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0004 affected2,914 at risk
- EG0016 affected2,937 at risk
|
| Atrial tachycardia | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Atrial thrombosis | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Atrioventricular block | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Atrioventricular block complete | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0014 affected2,937 at risk
|
| Bradyarrhythmia | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0016 affected2,937 at risk
|
| Bradycardia | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG00019 affected2,914 at risk
- EG00123 affected2,937 at risk
|
| Cardiac arrest | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0007 affected2,914 at risk
- EG0019 affected2,937 at risk
|
| Cardiac failure | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG00070 affected2,914 at risk
- EG00187 affected2,937 at risk
|
| Cardiac failure acute | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Cardiac failure chronic | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Cardiac failure congestive | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG00068 affected2,914 at risk
- EG00171 affected2,937 at risk
|
| Cardiac valve disease | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Cardio-respiratory arrest | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Cardiogenic shock | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Cardiomyopathy | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Chronotropic incompetence | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Coronary artery disease | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG00014 affected2,914 at risk
- EG00112 affected2,937 at risk
|
| Coronary artery occlusion | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Coronary artery stenosis | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Dressler's syndrome | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Left ventricular dysfunction | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Left ventricular failure | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Mitral valve incompetence | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0007 affected2,914 at risk
- EG0015 affected2,937 at risk
|
| Mitral valve stenosis | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Myocardial infarction | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Myocardial ischaemia | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Palpitations | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0004 affected2,914 at risk
- EG0015 affected2,937 at risk
|
| Pericardial effusion | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Pericarditis | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Right ventricular failure | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Sick sinus syndrome | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG00013 affected2,914 at risk
- EG00110 affected2,937 at risk
|
| Sinus arrest | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Sinus bradycardia | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Sinus tachycardia | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Tachycardia | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0015 affected2,937 at risk
|
| Tricuspid valve incompetence | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Ventricular arrhythmia | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0007 affected2,914 at risk
- EG0018 affected2,937 at risk
|
| Ventricular fibrillation | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0004 affected2,914 at risk
- EG0016 affected2,937 at risk
|
| Ventricular tachycardia | Cardiac disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0007 affected2,914 at risk
- EG0016 affected2,937 at risk
|
| Deafness | Ear and labyrinth disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Hearing impaired | Ear and labyrinth disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Vertigo | Ear and labyrinth disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0006 affected2,914 at risk
- EG0014 affected2,937 at risk
|
| Vertigo positional | Ear and labyrinth disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Addison's disease | Endocrine disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Goitre | Endocrine disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Hyperparathyroidism | Endocrine disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Hyperthyroidism | Endocrine disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Amaurosis fugax | Eye disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Blepharochalasis | Eye disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Blindness | Eye disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Cataract | Eye disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0008 affected2,914 at risk
- EG00110 affected2,937 at risk
|
| Diplopia | Eye disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Eye haemorrhage | Eye disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Glaucoma | Eye disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Macular pseudohole | Eye disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Optic ischaemic neuropathy | Eye disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Retinal detachment | Eye disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Retinal haemorrhage | Eye disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Retinal vein occlusion | Eye disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Scotoma | Eye disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Ulcerative keratitis | Eye disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Visual impairment | Eye disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Abdominal distension | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Abdominal hernia | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Abdominal mass | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Abdominal pain | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG00029 affected2,914 at risk
- EG00127 affected2,937 at risk
|
| Abdominal pain upper | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Anal fistula | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Ascites | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Colitis | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Colitis ischaemic | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Colonic obstruction | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Colonic polyp | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG00011 affected2,914 at risk
- EG0014 affected2,937 at risk
|
| Constipation | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Dental caries | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Diarrhoea | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0008 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Diverticulum | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Diverticulum intestinal | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Diverticulum intestinal haemorrhagic | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Duodenal polyp | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Duodenal ulcer | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0004 affected2,914 at risk
- EG0014 affected2,937 at risk
|
| Duodenal ulcer haemorrhage | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Duodenal ulcer perforation | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Dyspepsia | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0007 affected2,914 at risk
- EG00112 affected2,937 at risk
|
| Dysphagia | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Enterocolitis | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Gastric haemorrhage | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Gastric ulcer | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0008 affected2,914 at risk
- EG0015 affected2,937 at risk
|
| Gastric ulcer perforation | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Gastritis | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0008 affected2,914 at risk
- EG0017 affected2,937 at risk
|
| Gastritis erosive | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Gastritis haemorrhagic | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0014 affected2,937 at risk
|
| Gastrointestinal haemorrhage | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG00020 affected2,914 at risk
- EG00120 affected2,937 at risk
|
| Gastrointestinal mucosal disorder | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Gingival bleeding | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Haematemesis | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Haematochezia | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Haemorrhoidal haemorrhage | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Hiatus hernia | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Ileus | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0006 affected2,914 at risk
- EG0017 affected2,937 at risk
|
| Inguinal hernia | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG00013 affected2,914 at risk
- EG0017 affected2,937 at risk
|
| Inguinal hernia, obstructive | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Intestinal haemorrhage | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Intestinal ischaemia | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Intestinal obstruction | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0008 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Large intestinal obstruction | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Large intestinal ulcer | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Lower gastrointestinal haemorrhage | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0016 affected2,937 at risk
|
| Melaena | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0006 affected2,914 at risk
- EG0015 affected2,937 at risk
|
| Mesenteric artery stenosis | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Nausea | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Obstruction gastric | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Odynophagia | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Oesophageal achalasia | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Oesophageal obstruction | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Oesophageal rupture | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Oesophageal stenosis | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Oesophageal ulcer | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Oesophagitis | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Pancreatic cyst | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Pancreatitis | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0014 affected2,937 at risk
|
| Pancreatitis acute | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Peritoneal haemorrhage | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Rectal haemorrhage | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0005 affected2,914 at risk
- EG0015 affected2,937 at risk
|
| Rectal prolapse | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Salivary hypersecretion | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Small intestinal obstruction | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0005 affected2,914 at risk
- EG0016 affected2,937 at risk
|
| Subileus | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Upper gastrointestinal haemorrhage | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0004 affected2,914 at risk
- EG0015 affected2,937 at risk
|
| Vomiting | Gastrointestinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0006 affected2,914 at risk
- EG0016 affected2,937 at risk
|
| Adverse drug reaction | General disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Asthenia | General disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0007 affected2,914 at risk
- EG00110 affected2,937 at risk
|
| Chest discomfort | General disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Chest pain | General disorders | MEDDRA 15.1 | Systematic Assessment | | - EG00035 affected2,914 at risk
- EG00147 affected2,937 at risk
|
| Death | General disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Device breakage | General disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Device dislocation | General disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Device malfunction | General disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Drug ineffective | General disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Fatigue | General disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Gait disturbance | General disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| General physical health deterioration | General disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Generalised oedema | General disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Hernia | General disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0006 affected2,914 at risk
- EG0014 affected2,937 at risk
|
| Hernia obstructive | General disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Impaired healing | General disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Malaise | General disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Medical device complication | General disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Multi-organ disorder | General disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Multi-organ failure | General disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Necrosis | General disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Non-cardiac chest pain | General disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0005 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Oedema | General disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Oedema peripheral | General disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0005 affected2,914 at risk
- EG0014 affected2,937 at risk
|
| Pain | General disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Pyrexia | General disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0014 affected2,937 at risk
|
| Stent-graft endoleak | General disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Sudden cardiac death | General disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Sudden death | General disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Bile duct obstruction | Hepatobiliary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Bile duct stone | Hepatobiliary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0004 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Biliary colic | Hepatobiliary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Cholangitis | Hepatobiliary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0004 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Cholangitis acute | Hepatobiliary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Cholecystitis | Hepatobiliary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG00010 affected2,914 at risk
- EG0017 affected2,937 at risk
|
| Cholecystitis acute | Hepatobiliary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0004 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Cholelithiasis | Hepatobiliary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG00010 affected2,914 at risk
- EG0014 affected2,937 at risk
|
| Hepatic cirrhosis | Hepatobiliary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Hepatic failure | Hepatobiliary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Hepatic function abnormal | Hepatobiliary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Hepatitis toxic | Hepatobiliary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Hepatomegaly | Hepatobiliary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Hepatorenal syndrome | Hepatobiliary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Jaundice cholestatic | Hepatobiliary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Anaphylactic reaction | Immune system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Anaphylactic shock | Immune system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Abscess | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Abscess limb | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Abscess neck | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Anal abscess | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Appendicitis | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Arthritis bacterial | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Arthritis infective | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Atypical pneumonia | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Bacteraemia | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0004 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Brain abscess | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Bronchitis | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG00011 affected2,914 at risk
- EG0018 affected2,937 at risk
|
| Bronchitis viral | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Bronchopneumonia | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Cellulitis | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG00025 affected2,914 at risk
- EG00125 affected2,937 at risk
|
| Cellulitis staphylococcal | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Cholecystitis infective | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Chronic sinusitis | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Clostridial infection | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Clostridium difficile colitis | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Corneal abscess | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Cystitis | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Dengue fever | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Device related infection | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Diabetic foot infection | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Diverticulitis | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0016 affected2,937 at risk
|
| Ear infection | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Endocarditis | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0005 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Endocarditis bacterial | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Enterococcal sepsis | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Erysipelas | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0007 affected2,914 at risk
- EG0016 affected2,937 at risk
|
| Escherichia sepsis | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Escherichia urinary tract infection | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Eye infection | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Fungal infection | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Gangrene | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Gastric ulcer helicobacter | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Gastroenteritis | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0014 affected2,937 at risk
|
| Gastroenteritis cryptosporidial | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Gastroenteritis viral | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Gastrointestinal infection | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Groin abscess | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Groin infection | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Herpes ophthalmic | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Herpes zoster | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0014 affected2,937 at risk
|
| Herpes zoster ophthalmic | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Herpes zoster oticus | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Implant site infection | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Infected bites | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Infected cyst | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Infected skin ulcer | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Infection | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0005 affected2,914 at risk
- EG0015 affected2,937 at risk
|
| Infective exacerbation of chronic obstructive airways disease | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Influenza | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Klebsiella sepsis | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Labyrinthitis | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Liver abscess | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Lobar pneumonia | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Localised infection | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0004 affected2,914 at risk
- EG0015 affected2,937 at risk
|
| Lower respiratory tract infection | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Lung infection | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Nasopharyngitis | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Neuroborreliosis | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Oesophageal candidiasis | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Oesophageal infection | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Oral candidiasis | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Osteomyelitis | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0014 affected2,937 at risk
|
| Otitis externa | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Pancreatic abscess | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Parotitis | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Peritonitis | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Peritonitis bacterial | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Peritonsillar abscess | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Pharyngeal abscess | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Pharyngolaryngeal abscess | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Pneumonia | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG00091 affected2,914 at risk
- EG00199 affected2,937 at risk
|
| Pneumonia bacterial | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Pneumonia legionella | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Pneumonia pneumococcal | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Post procedural infection | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Postoperative wound infection | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Pyelonephritis | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Pyelonephritis acute | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Respiratory tract infection | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0005 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Sepsis | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG00019 affected2,914 at risk
- EG00123 affected2,937 at risk
|
| Septic shock | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Sinusitis | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Skin infection | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Staphylococcal bacteraemia | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Staphylococcal sepsis | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Staphylococcal skin infection | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Streptococcal bacteraemia | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Tuberculosis | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Upper respiratory tract infection | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0005 affected2,914 at risk
- EG0015 affected2,937 at risk
|
| Urethritis chlamydial | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Urinary tract infection | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG00021 affected2,914 at risk
- EG00129 affected2,937 at risk
|
| Urinary tract infection bacterial | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Urinary tract infection pseudomonal | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Urinary tract infection staphylococcal | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Urosepsis | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Viral infection | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Vulvovaginal candidiasis | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Wound infection | Infections and infestations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Alcohol poisoning | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Anaemia postoperative | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Ankle fracture | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0018 affected2,937 at risk
|
| Arterial injury | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Arthropod sting | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Carbon monoxide poisoning | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Cartilage injury | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Cervical vertebral fracture | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Comminuted fracture | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Concussion | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Contusion | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Craniocerebral injury | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Deafness traumatic | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Facial bones fracture | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Fall | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG00026 affected2,914 at risk
- EG00131 affected2,937 at risk
|
| Fat embolism | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Femoral neck fracture | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0004 affected2,914 at risk
- EG0019 affected2,937 at risk
|
| Femur fracture | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG00010 affected2,914 at risk
- EG0016 affected2,937 at risk
|
| Fibula fracture | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Fracture | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Hand fracture | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Head injury | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Hip fracture | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG00011 affected2,914 at risk
- EG00111 affected2,937 at risk
|
| Humerus fracture | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Iatrogenic injury | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Incision site haemorrhage | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Incisional hernia | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Jaw fracture | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Joint dislocation | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Joint injury | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Laceration | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Limb injury | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Lower limb fracture | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Lumbar vertebral fracture | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Meniscus lesion | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Multiple fractures | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Muscle rupture | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Open wound | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Overdose | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Pelvic fracture | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0004 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Post procedural haemorrhage | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Procedural hypertension | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Pubis fracture | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Radius fracture | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Rib fracture | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Road traffic accident | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0014 affected2,937 at risk
|
| Skin injury | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Skull fracture | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Snake bite | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Soft tissue injury | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Spinal compression fracture | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0005 affected2,914 at risk
- EG0015 affected2,937 at risk
|
| Sternal fracture | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Subdural haematoma | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0005 affected2,914 at risk
- EG0014 affected2,937 at risk
|
| Subdural haemorrhage | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Tendon injury | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Tendon rupture | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Tibia fracture | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Toxicity to various agents | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0005 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Traumatic arthritis | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Traumatic fracture | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Traumatic haematoma | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Ulna fracture | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Upper limb fracture | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Vascular pseudoaneurysm | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Wound dehiscence | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Wound necrosis | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Wrist fracture | Injury, poisoning and procedural complications | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Blood glucagon abnormal | Investigations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Blood glucose increased | Investigations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Creatinine renal clearance decreased | Investigations | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Haemoglobin decreased | Investigations | MEDDRA 15.1 | Systematic Assessment | | - EG0005 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Heart rate decreased | Investigations | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Heart rate irregular | Investigations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Hepatic enzyme increased | Investigations | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| International normalised ratio increased | Investigations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Liver function test abnormal | Investigations | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Platelet count decreased | Investigations | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Troponin I increased | Investigations | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Weight decreased | Investigations | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Dehydration | Metabolism and nutrition disorders | MEDDRA 15.1 | Systematic Assessment | | - EG00011 affected2,914 at risk
- EG00120 affected2,937 at risk
|
| Diabetes mellitus | Metabolism and nutrition disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Diabetes mellitus inadequate control | Metabolism and nutrition disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Diabetic complication | Metabolism and nutrition disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Diabetic ketoacidosis | Metabolism and nutrition disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Electrolyte imbalance | Metabolism and nutrition disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Failure to thrive | Metabolism and nutrition disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Fluid overload | Metabolism and nutrition disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Gout | Metabolism and nutrition disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0004 affected2,914 at risk
- EG0016 affected2,937 at risk
|
| Haemochromatosis | Metabolism and nutrition disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Hyperglycaemia | Metabolism and nutrition disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Hyperkalaemia | Metabolism and nutrition disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0004 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Hypoglycaemia | Metabolism and nutrition disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0004 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Hypokalaemia | Metabolism and nutrition disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Hypomagnesaemia | Metabolism and nutrition disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Hyponatraemia | Metabolism and nutrition disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0008 affected2,914 at risk
- EG0018 affected2,937 at risk
|
| Lactic acidosis | Metabolism and nutrition disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Malnutrition | Metabolism and nutrition disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Metabolic acidosis | Metabolism and nutrition disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Type 1 diabetes mellitus | Metabolism and nutrition disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Type 2 diabetes mellitus | Metabolism and nutrition disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Vitamin B12 deficiency | Metabolism and nutrition disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Arthralgia | Musculoskeletal and connective tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0009 affected2,914 at risk
- EG0017 affected2,937 at risk
|
| Arthritis | Musculoskeletal and connective tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0007 affected2,914 at risk
- EG0015 affected2,937 at risk
|
| Arthropathy | Musculoskeletal and connective tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Back pain | Musculoskeletal and connective tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0009 affected2,914 at risk
- EG00115 affected2,937 at risk
|
| Bursitis | Musculoskeletal and connective tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Cervical spinal stenosis | Musculoskeletal and connective tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Chondrocalcinosis pyrophosphate | Musculoskeletal and connective tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Crystal arthropathy | Musculoskeletal and connective tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Dupuytren's contracture | Musculoskeletal and connective tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Flank pain | Musculoskeletal and connective tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Foot deformity | Musculoskeletal and connective tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Intervertebral disc degeneration | Musculoskeletal and connective tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Intervertebral disc protrusion | Musculoskeletal and connective tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0014 affected2,937 at risk
|
| Jaw cyst | Musculoskeletal and connective tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Joint swelling | Musculoskeletal and connective tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Lumbar spinal stenosis | Musculoskeletal and connective tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0018 affected2,937 at risk
|
| Muscular weakness | Musculoskeletal and connective tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Musculoskeletal chest pain | Musculoskeletal and connective tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Musculoskeletal pain | Musculoskeletal and connective tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Neck pain | Musculoskeletal and connective tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Osteoarthritis | Musculoskeletal and connective tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG00028 affected2,914 at risk
- EG00136 affected2,937 at risk
|
| Pain in extremity | Musculoskeletal and connective tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0004 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Polyarthritis | Musculoskeletal and connective tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Polymyalgia rheumatica | Musculoskeletal and connective tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Pseudarthrosis | Musculoskeletal and connective tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Rhabdomyolysis | Musculoskeletal and connective tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Rheumatoid arthritis | Musculoskeletal and connective tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Rotator cuff syndrome | Musculoskeletal and connective tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Spinal column stenosis | Musculoskeletal and connective tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Spinal osteoarthritis | Musculoskeletal and connective tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Spondylolisthesis | Musculoskeletal and connective tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Synovitis | Musculoskeletal and connective tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Acute leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Adenoma benign | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Adrenal adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Angiosarcoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Basal cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Benign neoplasm of skin | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Bile duct cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Bladder cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0008 affected2,914 at risk
- EG0019 affected2,937 at risk
|
| Bladder neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Bladder transitional cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Bone neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Bone sarcoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Brain neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Brain neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Breast cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0008 affected2,914 at risk
- EG0019 affected2,937 at risk
|
| Breast cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Bronchial carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Carcinoid tumour | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Cervix carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Choroid melanoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Chronic lymphocytic leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Colon adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Colon cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG00013 affected2,914 at risk
- EG0016 affected2,937 at risk
|
| Colon cancer recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Colon cancer stage 0 | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Endometrial cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Gallbladder cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Gastric cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0004 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Gastric neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Gastrointestinal carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Gastrointestinal tract adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Gastrooesophageal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Glioblastoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Hepatic cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Hepatic neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Hepatic neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Hodgkin's disease | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Keratoacanthoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Langerhans' cell histiocytosis | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Large cell carcinoma of the respiratory tract stage unspecified | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Laryngeal cancer recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Lipoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Liposarcoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Lung adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Lung cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Lung carcinoma cell type unspecified recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Lung neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Lung neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG00016 affected2,914 at risk
- EG0015 affected2,937 at risk
|
| Lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0014 affected2,937 at risk
|
| Malignant melanoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0015 affected2,937 at risk
|
| Malignant neoplasm of pleura | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Meningioma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Metastases to bone | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Metastases to central nervous system | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Metastases to pelvis | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Metastatic neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Multiple myeloma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0006 affected2,914 at risk
- EG0015 affected2,937 at risk
|
| Neoplasm prostate | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Neuroendocrine carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Non-small cell lung cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Non-small cell lung cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Oesophageal adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Oesophageal carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Ovarian cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Pancreatic carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0014 affected2,937 at risk
|
| Pancreatic carcinoma metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Pancreatic neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Parathyroid tumour benign | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Phaeochromocytoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Prostate cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG00013 affected2,914 at risk
- EG00114 affected2,937 at risk
|
| Prostate cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Prostate cancer recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Rectal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Rectal cancer recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Rectal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Renal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Renal cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Small cell lung cancer stage unspecified | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Squamous cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Squamous cell carcinoma of skin | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0004 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Thymoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Thyroid cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Thyroid cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Tongue neoplasm malignant stage unspecified | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Transitional cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Ureteric cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Uterine cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Vulval cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Amnesia | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Aphasia | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Brachial plexopathy | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Brain stem stroke | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Carotid artery insufficiency | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Carotid artery occlusion | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Carotid artery stenosis | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0004 affected2,914 at risk
- EG0015 affected2,937 at risk
|
| Carotid sinus syndrome | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Carpal tunnel syndrome | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Cerebellar haemorrhage | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Cerebral haemorrhage | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Cerebral infarction | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Cerebral ischaemia | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Cerebrovascular accident | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0008 affected2,914 at risk
- EG0015 affected2,937 at risk
|
| Cervical root pain | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Chronic inflammatory demyelinating polyradiculoneuropathy | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Cognitive disorder | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Coma | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Convulsion | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0005 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Dementia | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Dementia Alzheimer's type | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Dizziness | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0004 affected2,914 at risk
- EG0017 affected2,937 at risk
|
| Embolic stroke | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Encephalopathy | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0004 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Epilepsy | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Grand mal convulsion | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Haemorrhage intracranial | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Haemorrhagic stroke | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Headache | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Hemiparesis | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Hydrocephalus | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Hypoaesthesia | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| IIIrd nerve paralysis | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Intraventricular haemorrhage | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Ischaemic stroke | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0005 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Lumbar radiculopathy | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Migraine | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Myasthenia gravis | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Myelopathy | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Neuropathy peripheral | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Normal pressure hydrocephalus | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Paraesthesia | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Paresis cranial nerve | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Parkinson's disease | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Parkinsonism | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Partial seizures | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Polyneuropathy | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Presyncope | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0014 affected2,937 at risk
|
| Sciatic nerve palsy | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Sciatica | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Subarachnoid haemorrhage | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Syncope | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG00024 affected2,914 at risk
- EG00124 affected2,937 at risk
|
| Transient ischaemic attack | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0006 affected2,914 at risk
- EG0014 affected2,937 at risk
|
| Tremor | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Trigeminal neuralgia | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| VIIth nerve paralysis | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Vertebrobasilar insufficiency | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Vertigo CNS origin | Nervous system disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Abnormal behaviour | Psychiatric disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Alcohol abuse | Psychiatric disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Alcohol withdrawal syndrome | Psychiatric disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Anxiety | Psychiatric disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Completed suicide | Psychiatric disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Confusional state | Psychiatric disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Delirium | Psychiatric disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Depression | Psychiatric disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0015 affected2,937 at risk
|
| Disorientation | Psychiatric disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Mental disorder | Psychiatric disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Mental status changes | Psychiatric disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0005 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Panic attack | Psychiatric disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Panic disorder | Psychiatric disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Suicide attempt | Psychiatric disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Bladder obstruction | Renal and urinary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Bladder prolapse | Renal and urinary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Dysuria | Renal and urinary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Glomerulonephritis | Renal and urinary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Haematuria | Renal and urinary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0017 affected2,937 at risk
|
| Hydronephrosis | Renal and urinary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Nephrolithiasis | Renal and urinary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0004 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Nephrotic syndrome | Renal and urinary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Proteinuria | Renal and urinary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Renal colic | Renal and urinary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Renal cyst | Renal and urinary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Renal disorder | Renal and urinary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Renal embolism | Renal and urinary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Renal failure | Renal and urinary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG00019 affected2,914 at risk
- EG0019 affected2,937 at risk
|
| Renal failure acute | Renal and urinary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG00023 affected2,914 at risk
- EG00123 affected2,937 at risk
|
| Renal failure chronic | Renal and urinary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Renal impairment | Renal and urinary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Renal infarct | Renal and urinary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Urethral stenosis | Renal and urinary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Urinary retention | Renal and urinary disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Benign prostatic hyperplasia | Reproductive system and breast disorders | MEDDRA 15.1 | Systematic Assessment | | - EG00012 affected2,914 at risk
- EG00113 affected2,937 at risk
|
| Ovarian cyst | Reproductive system and breast disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Pelvic haematoma | Reproductive system and breast disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Pelvic pain | Reproductive system and breast disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Spermatocele | Reproductive system and breast disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Uterine prolapse | Reproductive system and breast disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Vaginal haemorrhage | Reproductive system and breast disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Vaginal prolapse | Reproductive system and breast disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Acute pulmonary oedema | Respiratory, thoracic and mediastinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0014 affected2,937 at risk
|
| Acute respiratory failure | Respiratory, thoracic and mediastinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0004 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Alveolitis | Respiratory, thoracic and mediastinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Aspiration | Respiratory, thoracic and mediastinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Asthma | Respiratory, thoracic and mediastinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0004 affected2,914 at risk
- EG0014 affected2,937 at risk
|
| Bronchial secretion retention | Respiratory, thoracic and mediastinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Bronchitis chronic | Respiratory, thoracic and mediastinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Chronic obstructive pulmonary disease | Respiratory, thoracic and mediastinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG00027 affected2,914 at risk
- EG00130 affected2,937 at risk
|
| Dysphonia | Respiratory, thoracic and mediastinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Dyspnoea | Respiratory, thoracic and mediastinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG00034 affected2,914 at risk
- EG00132 affected2,937 at risk
|
| Dyspnoea exertional | Respiratory, thoracic and mediastinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Epistaxis | Respiratory, thoracic and mediastinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Haemoptysis | Respiratory, thoracic and mediastinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Haemothorax | Respiratory, thoracic and mediastinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Hypercapnia | Respiratory, thoracic and mediastinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Hypoxia | Respiratory, thoracic and mediastinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Idiopathic pulmonary fibrosis | Respiratory, thoracic and mediastinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Laryngeal oedema | Respiratory, thoracic and mediastinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Pleural effusion | Respiratory, thoracic and mediastinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG00011 affected2,914 at risk
- EG0017 affected2,937 at risk
|
| Pleuritic pain | Respiratory, thoracic and mediastinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Pneumonia aspiration | Respiratory, thoracic and mediastinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Pneumothorax | Respiratory, thoracic and mediastinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Productive cough | Respiratory, thoracic and mediastinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Pulmonary congestion | Respiratory, thoracic and mediastinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Pulmonary embolism | Respiratory, thoracic and mediastinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Pulmonary fibrosis | Respiratory, thoracic and mediastinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Pulmonary haemorrhage | Respiratory, thoracic and mediastinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Pulmonary hypertension | Respiratory, thoracic and mediastinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Pulmonary mass | Respiratory, thoracic and mediastinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Pulmonary oedema | Respiratory, thoracic and mediastinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0015 affected2,937 at risk
|
| Respiratory distress | Respiratory, thoracic and mediastinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0014 affected2,937 at risk
|
| Respiratory failure | Respiratory, thoracic and mediastinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0006 affected2,914 at risk
- EG0015 affected2,937 at risk
|
| Sleep apnoea syndrome | Respiratory, thoracic and mediastinal disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Decubitus ulcer | Skin and subcutaneous tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Diabetic foot | Skin and subcutaneous tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Eczema | Skin and subcutaneous tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Pemphigoid | Skin and subcutaneous tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Psoriasis | Skin and subcutaneous tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Purpura | Skin and subcutaneous tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Rash | Skin and subcutaneous tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Skin discolouration | Skin and subcutaneous tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Skin haemorrhage | Skin and subcutaneous tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Skin lesion | Skin and subcutaneous tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Skin ulcer | Skin and subcutaneous tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0003 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Stasis dermatitis | Skin and subcutaneous tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Urticaria | Skin and subcutaneous tissue disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Activities of daily living impaired | Social circumstances | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Dental implantation | Surgical and medical procedures | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Lesion excision | Surgical and medical procedures | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Tooth extraction | Surgical and medical procedures | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Aneurysm | Vascular disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Aortic aneurysm | Vascular disorders | MEDDRA 15.1 | Systematic Assessment | | - EG00011 affected2,914 at risk
- EG0018 affected2,937 at risk
|
| Aortic aneurysm rupture | Vascular disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Aortic dissection | Vascular disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0005 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Aortic intramural haematoma | Vascular disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Aortic stenosis | Vascular disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0006 affected2,914 at risk
- EG0016 affected2,937 at risk
|
| Arteriosclerosis | Vascular disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Arteritis | Vascular disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Blood pressure inadequately controlled | Vascular disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Circulatory collapse | Vascular disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Deep vein thrombosis | Vascular disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0016 affected2,937 at risk
|
| Femoral artery aneurysm | Vascular disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Femoral artery occlusion | Vascular disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Haematoma | Vascular disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0013 affected2,937 at risk
|
| Haemorrhage | Vascular disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0004 affected2,914 at risk
- EG0015 affected2,937 at risk
|
| Hypertension | Vascular disorders | MEDDRA 15.1 | Systematic Assessment | | - EG00011 affected2,914 at risk
- EG00110 affected2,937 at risk
|
| Hypertensive crisis | Vascular disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Hypotension | Vascular disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0008 affected2,914 at risk
- EG0019 affected2,937 at risk
|
| Intermittent claudication | Vascular disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Ischaemia | Vascular disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Leriche syndrome | Vascular disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Malignant hypertension | Vascular disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Orthostatic hypotension | Vascular disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Peripheral arterial occlusive disease | Vascular disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0004 affected2,914 at risk
- EG0012 affected2,937 at risk
|
| Peripheral artery aneurysm | Vascular disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Peripheral artery stenosis | Vascular disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0014 affected2,937 at risk
|
| Peripheral artery thrombosis | Vascular disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Peripheral embolism | Vascular disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Peripheral ischaemia | Vascular disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Peripheral vascular disorder | Vascular disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0002 affected2,914 at risk
- EG0014 affected2,937 at risk
|
| Shock haemorrhagic | Vascular disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0000 affected2,914 at risk
- EG0011 affected2,937 at risk
|
| Temporal arteritis | Vascular disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Thrombosis | Vascular disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|
| Venous occlusion | Vascular disorders | MEDDRA 15.1 | Systematic Assessment | | - EG0001 affected2,914 at risk
- EG0010 affected2,937 at risk
|